PD-L1 degradation is regulated by electrostatic membrane association of its cytoplasmic domain

Maorong Wen,Yunlei Cao,Bin Wu,Taoran Xiao,Ruiyu Cao,Qian Wang,Xiwei Liu,Hongjuan Xue,Yang Yu,Jialing Lin,Chenqi Xu,Jie Xu,Bo OuYang

DOI: https://doi.org/10.1038/s41467-021-25416-7

IF: 16.6

2021-01-01

Nature Communications

Abstract:The cytoplasmic domain of PD-L1 (PD-L1-CD) regulates PD-L1 degradation and stability through various mechanism, making it an attractive target for blocking PD-L1-related cancer signaling. Here, by using NMR and biochemical techniques we find that the membrane association of PD-L1-CD is mediated by electrostatic interactions between acidic phospholipids and basic residues in the N-terminal region. The absence of the acidic phospholipids and replacement of the basic residues with acidic residues abolish the membrane association. Moreover, the basic-to-acidic mutations also decrease the cellular abundance of PD-L1, implicating that the electrostatic interaction with the plasma membrane mediates the cellular levels of PD-L1. Interestingly, distinct from its reported function as an activator of AMPK in tumor cells, the type 2 diabetes drug metformin enhances the membrane dissociation of PD-L1-CD by disrupting the electrostatic interaction, thereby decreasing the cellular abundance of PD-L1. Collectively, our study reveals an unusual regulatory mechanism that controls the PD-L1 level in tumor cells, suggesting an alternative strategy to improve the efficacy of PD-L1-related immunotherapies.